JP2008528700A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528700A5
JP2008528700A5 JP2007554257A JP2007554257A JP2008528700A5 JP 2008528700 A5 JP2008528700 A5 JP 2008528700A5 JP 2007554257 A JP2007554257 A JP 2007554257A JP 2007554257 A JP2007554257 A JP 2007554257A JP 2008528700 A5 JP2008528700 A5 JP 2008528700A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
ylmethoxy
phenoxy
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007554257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/003924 external-priority patent/WO2006084176A2/en
Publication of JP2008528700A publication Critical patent/JP2008528700A/ja
Publication of JP2008528700A5 publication Critical patent/JP2008528700A5/ja
Pending legal-status Critical Current

Links

JP2007554257A 2005-02-03 2006-02-03 Pparモジュレーターとしての化合物および組成物 Pending JP2008528700A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64996205P 2005-02-03 2005-02-03
PCT/US2006/003924 WO2006084176A2 (en) 2005-02-03 2006-02-03 Compounds and compositions as ppar modulators

Publications (2)

Publication Number Publication Date
JP2008528700A JP2008528700A (ja) 2008-07-31
JP2008528700A5 true JP2008528700A5 (cg-RX-API-DMAC7.html) 2008-10-09

Family

ID=36777985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554257A Pending JP2008528700A (ja) 2005-02-03 2006-02-03 Pparモジュレーターとしての化合物および組成物

Country Status (10)

Country Link
US (1) US7750032B2 (cg-RX-API-DMAC7.html)
EP (1) EP1843763A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008528700A (cg-RX-API-DMAC7.html)
KR (1) KR100929069B1 (cg-RX-API-DMAC7.html)
CN (1) CN101141957A (cg-RX-API-DMAC7.html)
AU (1) AU2006210503B2 (cg-RX-API-DMAC7.html)
CA (1) CA2595789A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007009356A (cg-RX-API-DMAC7.html)
RU (1) RU2007132973A (cg-RX-API-DMAC7.html)
WO (1) WO2006084176A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
SG178880A1 (en) 2009-08-26 2012-04-27 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
CN103298469A (zh) 2010-08-31 2013-09-11 首尔大学校产学协力财团 PPARδ激动剂的胎儿重编程的用途
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013099806A1 (ja) * 2011-12-29 2013-07-04 Taoヘルスライフファーマ株式会社 アミロスフェロイドが結合して成熟神経細胞死を誘発する標的分子、アミロスフェロイドが誘導する神経細胞死を抑制する方法及び物質、及びそれらの利用
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US11497738B2 (en) 2016-04-29 2022-11-15 Fgh Biotech, Inc. Di-substituted pyrazole compounds for the treatment of diseases
EP3510027B1 (en) * 2016-09-07 2022-11-02 FGH BioTech, Inc. Di-substituted pyrazole compounds for the treatment of diseases
CN109843857B (zh) * 2016-10-05 2023-01-06 米托布里奇公司 Ppar激动剂化合物的结晶和盐形式
US20210324067A9 (en) * 2018-03-09 2021-10-21 The Brigham And Women's Hospital, Inc. Combination therapy for cardiovascular diseases
BR112021002207A2 (pt) 2018-08-10 2021-05-04 Diapin Therapeutics, Llc tri-peptídeos e tratamento de distúrbios metabólicos, cardiovasculares e inflamatórios
CN113527269A (zh) * 2020-04-17 2021-10-22 上海京新生物医药有限公司 一种匹伐他汀钙氧化杂质的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en) * 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
US6350892B1 (en) * 1997-09-23 2002-02-26 Bristol-Myers Squibb Company Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
PE20030547A1 (es) * 2001-09-24 2003-08-18 Bayer Corp Derivados de imidazol para el tratamiento de la obesidad
DE60329073D1 (de) * 2002-01-18 2009-10-15 Merck & Co Inc Edg-rezeptoragonisten
US7507832B2 (en) * 2003-12-22 2009-03-24 Eli Lilly And Company Triazole PPAR modulators

Similar Documents

Publication Publication Date Title
RU2008135128A (ru) Производные спироимидазола в качестве модуляторов ppar
RU2007132973A (ru) Соединения и композиции в качестве модуляторов ppar
RU2008135126A (ru) Полициклические производные тетрагидроизохинолина и содержащие их композиции в качестве модуляторов ppar
RU2008135125A (ru) Соединения и композиции в качестве модуляторов ppar
JP2007537286A5 (cg-RX-API-DMAC7.html)
RU2006145894A (ru) Соединения и композиции, как модуляторы активированных рецепторов пролифератора пероксисомы
RU2006144124A (ru) Соединения и композиции в качестве модуляторов ppar-рецепторов, активируемых пролифератором пероксисом
RU2006145893A (ru) Соединения и композиции, как модуляторы активированных рецепторов пролифератора периксисомы
US9670193B2 (en) Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
US10538502B2 (en) Tricyclic spiro compound
KR101616133B1 (ko) Dgat1 억제제로서의 옥사디아졸- 및 옥사졸-치환된 벤즈이미다졸- 및 인돌-유도체
US20070191371A1 (en) Heterocyclic modulators of ppar
RU2006144121A (ru) Соединения и композиции в качестве модуляторов ppar рецепторов, активируемых пролифератором пероксисом
JP2010515715A5 (cg-RX-API-DMAC7.html)
RU2008122547A (ru) Соединения и композиции как модуляторы арпп (активированных рецепторов пролифератора пероксисом)
CA2674436A1 (en) Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
JP2015533157A (ja) [オルトビ−(ヘテロ−)アリール]−[2−(メタビ−(ヘテロ−)アリール)−ピロリジン−1−イル]−メタノン誘導体であるオレキシン受容体アンタゴニスト
RU2008122548A (ru) Соединения и композиции, как модуляторы арпп (активированных рецепторов пролифератора пероксисом)
JPWO2018216640A1 (ja) Ep4アンタゴニスト
JP2008528441A5 (cg-RX-API-DMAC7.html)
JP2007537287A5 (cg-RX-API-DMAC7.html)
RU2008122546A (ru) Оксазоловый и тиазоловый модулятор арпп (активированных рецепторов пролифератора пероксисом)
CN104995188B (zh) 2-((1r,4r)-4-(4-(5-(苯并噁唑-2-基氨基)吡啶-2-基)苯基)环己基)乙酸的葡甲胺盐形式和它们作为dgat1抑制剂的用途
ZA200608731B (en) Compounds and compositions as PPAR modulators
TH81346A (th) สารประกอบและองค์ประกอบในฐานะเป็นตัวคุม ppar